drugset / Trial / NCT01048268
Glucose-dependent Insulinotropic Polypeptide - New Role as Blood Glucose Stabilizer?
RandomizedParallel-groupQuadruple-blindBasic science
Summary
The purpose of this study is to determine whether glucose-dependent insulinotropic polypeptide (GIP) has a stabilizing function on the blood glucose
Timeline
- Start
- 2009-12
- Primary completion
- 2014-04
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glucose-dependent Insulinotropic Polypeptide | Peptide | 2 unknown | Intravenous |